Showing results (511-520 of 635) with videos related to

Sort By:
Pageof 64
Oncotarget|September 10, 2016
Role of TP53 mutations in triple negative and HER2-positive breast cancer treated with neoadjuvant anthracycline/taxane-based chemotherapySilvia Darb-Esfahani, Carsten Denkert, Albrecht Stenzinger, et al.
Cold Spring Harbor Molecular Case Studies|March 6, 2019
Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistancePeter Horak, Joachim Weischenfeldt, Gunhild von Amsberg, et al.
International Journal of Cancer|September 25, 2024
Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcomeMarcel Wiesweg, Claudia Küter, Johannes Schnorbach, et al.
European Journal of Endocrinology|June 1, 2023
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort studyHanna Remde, Laura Schmidt-Pennington, Miriam Reuter, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2021
Validation of a Targeted Next-Generation Sequencing Panel for Tumor Mutation Burden Analysis: Results from the Onconetwork Immuno-Oncology ConsortiumFrancesca Fenizia, Ilaria Alborelli, Jose Luis Costa, et al.
Cancer Immunology, Immunotherapy : CII|June 14, 2021
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2021
Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signatureChristian Koelsche, Jamal K Benhamida, Felix K F Kommoss, et al.
Cancers|June 21, 2020
Deep Learning for the Classification of Small-Cell and Non-Small-Cell Lung CancerMark Kriegsmann, Christian Haag, Cleo-Aron Weis, et al.
Pageof 64